Refractory Kawasaki disease: Infliximab or methotrexate therapy?

被引：0
|
作者：
Jae Il Shin
Jae Seung Lee
Jae Young Choi
Dong Soo Kim
Meenakshi Girish
机构：
[1] Yonsei University College of Medicine,Department of Pediatrics
[2] Severance Children’s Hospital,Dept of Pediatrics
[3] NKPSIMS,undefined
来源：
The Indian Journal of Pediatrics | 2009年 / 76卷 / 11期
关键词：
Infliximab; Kawasaki Disease; Coronary Artery Aneurysm; Kawasaki Disease Patient; Tumor Necrosis Factor Alpha Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1184 / 1184
相关论文
共 50 条
  • [31] Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review
    Courtney B. Crayne
    Chace Mitchell
    Timothy Beukelman
    Pediatric Rheumatology, 17
  • [32] Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review
    Crayne, Courtney B.
    Mitchell, Chace
    Beukelman, Timothy
    PEDIATRIC RHEUMATOLOGY, 2019, 17 (01)
  • [33] Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial
    Ogata, Shohei
    Ogihara, Yoshihito
    Honda, Takashi
    Kon, Shinya
    Akiyama, Kazumasa
    Ishii, Masahiro
    PEDIATRICS, 2012, 129 (01) : E17 - E23
  • [34] Effect Of Infliximab And Plasma Exchange Therapy On Activated Monocytes/macrophages In Kawasaki Disease Intractable
    Koizumi, Keiichi
    Katsumata, Nobuyuki
    Toda, Takako
    Kise, Hiroaki
    Hasebe, Yohei
    Sugita, Kanji
    Hosiai, Minako
    CIRCULATION, 2015, 131
  • [35] Infliximab in the treatment of adult Still's disease refractory to conventional therapy
    Cavagna, L
    Caporali, R
    Epis, O
    Bobbio-Pallavicini, F
    Montecucco, C
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (03) : 329 - 332
  • [36] Autoantibody induction in patients with refractory spondyloarthropathy treated with infliximab and methotrexate
    Sellam, J
    Allanore, Y
    Batteux, F
    Deslandre, CJ
    Weill, B
    Kahan, A
    JOINT BONE SPINE, 2005, 72 (01) : 48 - 52
  • [37] Effectiveness of infliximab in a patient with Behcet's disease refractory to immunosuppressive therapy
    Tacoronte, Angeles
    Gonzalez, Diana
    Sanchez, Miriam
    Moreno, Francisco
    Larrubia, Yolanda
    Villamanan, Elena
    Jimenez, Esperanza
    PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 130 - 131
  • [38] Infliximab treatment for late-onset arthritis associated with Kawasaki disease
    Matsubara, Kohei
    Togawa, Masao
    Tada, Masahiro
    Kitaguchi, Aya
    Amo, Kiyoko
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [39] SAFETY OF INFLIXIMAB AFTER LIVE VIRUS VACCINATION IN KAWASAKI DISEASE PATIENTS
    Lee, Aaron M.
    Burns, Jane C.
    Tremoulet, Adriana H.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (04) : 435 - 437
  • [40] Use of Infliximab in the Treatment of Macrophage Activation Syndrome Complicating Kawasaki Disease
    Rivera-Rodriguez, Leonardo
    Pardo-Diaz, Edwin
    Moreno-Espinosa, Sarbelio
    Scheffler-Mendoza, Selma
    Ruiz-Ontiveros, Marco A.
    Martin Garrido-Garcia, Luis
    Iglesias-Amaya, Andrea
    Yamazaki-Nakashimada, Marco A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (03) : E448 - E451
12345